Our Mission
AI Health Guide exists because the AI health market — a $38 billion industry — lacks an independent editorial voice. Most "best AI health apps" articles are written by vendors ranking themselves first (Freed ranks Freed first, DeepScribe ranks DeepScribe first, Glass Health ranks Glass Health first). Generic publishers cover AI health without clinical credentials or hands-on testing.
We bridge two audiences that no other comparison site serves together: consumers evaluating mental health apps, fitness coaches, and symptom checkers, and clinicians evaluating AI medical scribes, diagnostic tools, and practice management platforms. This dual-audience approach gives us comprehensive topical authority that single-audience sites cannot match.
How We Make Money
We earn money through affiliate commissions on consumer health apps (BetterHelp, Headspace, Noom, Cronometer, and others) and through the sole B2B affiliate opportunity (Freed at $50/subscriber). We do not earn affiliate commissions from most B2B clinical tools — Nuance DAX, Abridge, Suki, DeepScribe, Viz.ai, Aidoc, and Tempus have no affiliate programs accessible to content publishers.
Affiliate commissions never influence our rankings. We report Cerebral's $7M FTC settlement despite Cerebral's affiliate program ($12/signup). We report Calm's 1.4/5 Trustpilot score despite Calm's 20% affiliate commission. We report K Health's below-GP diagnostic accuracy (36% vs 82%) transparently.
Read our full methodology for details on our evaluation process and editorial independence policy.
What We Cover
We currently review 30 AI health platforms across two audience segments:
- 15 Consumer Health Apps (B2C): Mental health (BetterHelp, Headspace, Wysa, Cerebral, Calm, Woebot), weight loss and coaching (Noom, Lark Health, Hims & Hers), fitness (Zing Coach, Future, Freeletics), nutrition (Cronometer), symptom checking (Ada Health, K Health)
- 15 Clinical AI Tools (B2B): AI medical scribes (Nuance DAX, Suki, Freed, DeepScribe, Abridge), diagnostic AI (Viz.ai, Aidoc, Tempus AI, PathAI), practice management (athenahealth, DrChrono, Phreesia), clinical AI (Regard), telehealth (Amwell, Fabric Health)
YMYL Editorial Standards
AI health is a Your Money or Your Life (YMYL) topic. We hold ourselves to higher standards than non-health comparison sites:
- Medical disclaimer on every page
- Crisis resources (988 Lifeline, Crisis Text Line) on every mental health page
- Clinical evidence cited to PubMed, JMIR, FDA.gov, and KLAS Research
- No medical advice — we compare tools, we do not prescribe treatments
- Negative findings reported alongside positive (Trustpilot scores, FTC settlements, diagnostic accuracy data)
- All reviews updated every 90 days or upon major platform changes
- Factual errors corrected within 48 hours of confirmation
Editorial Team
AI Health Guide is written and maintained by health tech researchers and journalists, with licensed clinicians serving as medical advisors for YMYL content review. Our editorial contributors have backgrounds in health technology reporting, clinical informatics, and digital health product analysis — they understand both the technology and the clinical context in which these tools operate.
All YMYL medical content is reviewed by licensed clinicians (MDs, PhDs in clinical psychology) for accuracy before publication. We do not employ practicing physicians who would face conflicts of interest with reviewed platforms. Clinical advisors review content for medical accuracy and appropriate risk disclosure; they do not participate in affiliate or ranking decisions.
We use role-based attribution rather than individual bylines. Each review is written by the contributor with the deepest knowledge of that platform category (consumer mental health, clinical AI scribes, diagnostic tools), cross-checked by at least one other team member, and verified against primary sources (PubMed, JMIR, FDA.gov, KLAS Research, G2, and vendor documentation) before publication. Reviews are re-validated every 90 days, and we disclose our evaluation methodology, clinical evidence citations, and any limitations in our testing.
Conflict of interest policy: we do not employ active clinicians or health tech consultants who maintain commercial relationships with the platforms we review. Clinical advisors disclose any affiliations, and anyone with an active engagement with a vendor is recused from that vendor's review cycle. Corrections can be sent to hello@ai-health-apps.com and are addressed within 48 hours of confirmation.
Medical Advisory Board
Our medical advisory board includes board-certified reviewers spanning psychiatry (for mental health content), primary care (for clinical documentation content), and health IT (for technical validation). Advisors review YMYL content for clinical accuracy, appropriate risk framing, and regulatory context. We list advisor credentials and specialties on review pages where their input was material.
Advisors are compensated via flat editorial fees — never through affiliate commissions, platform referral arrangements, or equity in reviewed companies. This structure ensures their clinical judgment remains independent of our revenue model.
Contact Us
Corrections: Found an error? Email hello@ai-health-apps.com. We correct confirmed errors within 48 hours.
Platform suggestions: Know a platform we should review? Send details to the same address.
Medical advisory board inquiries: Physicians interested in joining our advisory board can contact us at hello@ai-health-apps.com.
Press and partnerships: hello@ai-health-apps.com